Neurosurgical Management in Anticoagulated Patient: Always a Challenge

被引：0

作者：

Rafael Moscote-Salazar, Luis ^{[1
]}

Agrawal, Amit ^{[2
]}

机构：

[1] Univ Cartagena, Crit Care, Bolivar, Colombia

[2] Maharishi Markandeshwar Univ Mullana, MM Inst Med Sci & Res, Ambala, Haryana, India

来源：

关键词：

IDARUCIZUMAB; DABIGATRAN; REVERSAL;

D O I：

10.1016/j.wneu.2017.10.126

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：297 / 297

页数：1

共 6 条

[1] Safe Burr Hole Surgery for Chronic Subdural Hematoma Using Dabigatran with Idarucizumab
Arai, Nobuhiko
Mine, Yutaka
Kagami, Hiroshi
Maruyama, Michiyuki
Daikoh, Atsushi
Inaba, Makoto
[J]. WORLD NEUROSURGERY, 2018, 109 : 432 - 435
[2] Awad K, 2017, AUSTIN J CEREBROVASC, V4, P1053
[3] Camm AJ, 2010, EUR HEART J, V31, P2369, DOI [10.1093/eurheartj/ehq278, 10.1093/europace/euq350]
[4] Safety, tolerability, and efficacy of idarucizumab for the reversal of the anticoagulant effect of dabigatran in healthy male volunteers: a randomised, placebo-controlled, double-blind phase 1 trial
Glund, Stephan
Stangier, Joachim
Schmohl, Michael
Gansser, Dietmar
Norris, Stephen
van Ryn, Joanne
Lang, Benjamin
Ramael, Steven
Moschetti, Viktoria
Gruenenfelder, Fredrik
Reilly, Paul
Kreuzer, Joerg
[J]. LANCET, 2015, 386 (9994) : 680 - 690
[5] Idarucizumab Improves Outcome in Murine Brain Hemorrhage Related to Dabigatran
Na, Shin-Young
Mracsko, Eva
van Ryn, Joanne
Veltkamp, Roland
[J]. ANNALS OF NEUROLOGY, 2015, 78 (01) : 137 - 141
[6] Design and rationale for RE-VERSE AD: A phase 3 study of idarucizumab, a specific reversal agent for dabigatran
Pollack, Charles V., Jr.
Reilly, Paul A.
Bernstein, Richard
Dubiel, Robert
Eikelboom, John
Glund, Stephan
Huisman, Menno V.
Hylek, Elaine
Kam, Chak-Wah
Kamphuisen, Pieter W.
Kreuzer, Joerg
Levy, Jerrold H.
Sellke, Frank
Stangier, Joachim
Steiner, Thorsten
Wang, Bushi
Weitz, Jeffrey I.
[J]. THROMBOSIS AND HAEMOSTASIS, 2015, 114 (01) : 198 - 205